Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Soleno Therapeutics (SLNO) Q1 2026 Earnings
SLNO
25
Feb
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.97
-0.38
0.21
0.8
Details
Expected EPS
0.710769
Actual EPS
0.8
Surprise EPS
0.09
Surprise Percent
+12.55%
Description
Soleno Therapeutics (SLNO) has reported earnings of 0.8 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login